Current treatment options of T cell-associated immunotherapy in multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s10238-017-0450-9
Published Online: 2017-01-24
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Hailing
Pan, Yunbao
Meng, Shan
Zhang, Wanggang
Zhou, Fuling
Funding for this research was provided by:
National Natural Science Foundation of China (81270597, 81172257)
License valid from 2017-01-24